Literature DB >> 10945808

Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.

P K Pal1, A Samii, A Kishore, M Schulzer, E Mak, S Yardley, I M Turnbull, D B Calne.   

Abstract

OBJECTIVES: With the advent of new antiparkinsonian drug therapy and promising results from subthalamic and pallidal stimulation, this study evaluated the long term efficacy of unilateral pallidotomy, a technique which has gained popularity over the past decade for the management of advanced Parkinson's disease.
METHODS: The 15 patients reported here are part of the original cohort of 24 patients who underwent posteroventral pallidotomy for motor fluctuations and disabling dyskinesias 3 years ago as part of a prospective study. Evaluation scales included the unified Parkinson's disease rating scale, the Goetz dyskinesia scale, and the Purdue pegboard test.
RESULTS: When compared with the prepallidotomy scores, the reduction in the limb dyskinesias and off state tremor scores persisted on the side contralateral to pallidotomy at the end of 3 years (dyskinesias were reduced by 64% (p<0.01) and tremor by 63% (p<0.05). Other measures tended to deteriorate. The dosage of antiparkinsonian medications did not change significantly from 3 months prepallidotomy to 3 years postpallidotomy.
CONCLUSIONS: Although unilateral pallidotomy is useful in controlling the contralateral dyskinesias and tremor 3 years after surgery, all other early benefits disappear and activities of daily living continue to worsen.

Entities:  

Mesh:

Year:  2000        PMID: 10945808      PMCID: PMC1737095          DOI: 10.1136/jnnp.69.3.337

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

Review 1.  Criteria for diagnosing Parkinson's disease.

Authors:  D B Calne; B J Snow; C Lee
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

2.  Posteroventral medial pallidotomy in advanced Parkinson's disease.

Authors:  A E Lang; A M Lozano; E Montgomery; J Duff; R Tasker; W Hutchinson
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

3.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

Authors:  L V Laitinen; A T Bergenheim; M I Hariz
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

4.  Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.

Authors:  A D Korczyn; D J Brooks; E R Brunt; W H Poewe; O Rascol; F Stocchi
Journal:  Mov Disord       Date:  1998-01       Impact factor: 10.338

5.  Assessment of motor function after stereotactic pallidotomy.

Authors:  W G Ondo; J Jankovic; E C Lai; C Sankhla; M Khan; L Ben-Arie; K Schwartz; R G Grossman; J K Krauss
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

6.  Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients.

Authors:  R J Uitti; R E Wharen; M F Turk; J A Lucas; M J Finton; N R Graff-Radford; K B Boylan; S J Goerss; B A Kall; C H Adler; J N Caviness; E J Atkinson
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

7.  Preoperative indicators of clinical outcome following stereotaxic pallidotomy.

Authors:  K Kazumata; A Antonini; V Dhawan; J R Moeller; R L Alterman; P Kelly; D Sterio; E Fazzini; A Beric; D Eidelberg
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

8.  Pallidotomy and bradykinesia: implications for basal ganglia function.

Authors:  K D Pfann; R D Penn; K M Shannon; D M Corcos
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

Authors:  R Kumar; A M Lozano; Y J Kim; W D Hutchison; E Sime; E Halket; A E Lang
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease.

Authors:  D Masterman; A DeSalles; R W Baloh; R Frysinger; D Foti; E Behnke; C Cabatan-Awang; A Hoetzel; P M Intemann; L Fairbanks; J M Bronstein
Journal:  Arch Neurol       Date:  1998-09
View more
  4 in total

1.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 2.  Parkinson's disease: surgical options.

Authors:  J Hammerstad; P Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

3.  Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.

Authors:  Adriana M Strutt; Eugene C Lai; Joseph Jankovic; Farah Atassi; Elizabeth M Soety; Harvey S Levin; Robert G Grossman; Michele K York
Journal:  Surg Neurol       Date:  2008-06-02

4.  Radiofrequency Lesioning for Movement and Psychiatric Disorders-Experience of 107 Cases.

Authors:  Paresh K Doshi
Journal:  Front Hum Neurosci       Date:  2021-06-14       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.